MYCN and neuroblastoma: Our results further support the involvement of miRNAs in neuroblastoma, validating the utility of TH-MYCN mouse model for studying the role of miRNAs in this pathology and for possible pre-clinical trials based on miRNA agonist/antagonist molecules.